Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
On October 3, 2023, Syneos Health, Inc. (the “Company”) publicly announced that Colin Shannon has been appointed Chief Executiv...
Syneos Health® (NASDAQ:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic ...
Syneos Health® (NASDAQ:SYNH) a leading fully integrated biopharmaceutical solutions organization, today announced that it has ...
Syneos Health, Inc. (NASDAQ:SYNH) ("Syneos Health" or the "Company"), a leading fully integrated biopharmaceuti...
● The study marks Click's second active randomized clinical trial testing digital interventions in migraine patients. ● Th...
